505 related articles for article (PubMed ID: 19362455)
1. Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
Inayat-ur-Rahman ; Malik SA; Bashir M; Khan R; Iqbal M
Phytomedicine; 2009 May; 16(5):401-5. PubMed ID: 19362455
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
Fuangchan A; Sonthisombat P; Seubnukarn T; Chanouan R; Chotchaisuwat P; Sirigulsatien V; Ingkaninan K; Plianbangchang P; Haines ST
J Ethnopharmacol; 2011 Mar; 134(2):422-8. PubMed ID: 21211558
[TBL] [Abstract][Full Text] [Related]
4. Serum sialic acid changes in type 2 diabetic patients on metformin or rosiglitazone treatment.
Rahman IU; Malik SA; Bashir M; Khan RU; Idrees M
J Clin Pharm Ther; 2010 Dec; 35(6):685-90. PubMed ID: 21054460
[TBL] [Abstract][Full Text] [Related]
5. The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats.
Senanayake GV; Maruyama M; Shibuya K; Sakono M; Fukuda N; Morishita T; Yukizaki C; Kawano M; Ohta H
J Ethnopharmacol; 2004 Apr; 91(2-3):257-62. PubMed ID: 15120448
[TBL] [Abstract][Full Text] [Related]
6. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
Shih CC; Lin CH; Lin WL; Wu JB
J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
Antivir Ther; 2003 Jun; 8(3):199-207. PubMed ID: 12924536
[TBL] [Abstract][Full Text] [Related]
8. Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients.
Hwang YC; Lee EY; Lee WJ; Cha BS; Yoon KH; Park KS; Lee MK
Metabolism; 2008 Apr; 57(4):479-87. PubMed ID: 18328348
[TBL] [Abstract][Full Text] [Related]
9. The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
Sarafidis PA; Lasaridis AN; Nilsson PM; Mouslech TF; Hitoglou-Makedou AD; Stafylas PC; Kazakos KA; Yovos JG; Tourkantonis AA
Metabolism; 2005 Sep; 54(9):1236-42. PubMed ID: 16125536
[TBL] [Abstract][Full Text] [Related]
10. Serum sialic acid in subjects with impaired glucose tolerance and in newly diagnosed type 2 diabetic patients.
Gavella M; Lipovac V; Car A; Vucić M; Sokolić L; Rakos R
Acta Diabetol; 2003 Jun; 40(2):95-100. PubMed ID: 12861408
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus.
Kim K; Kim H; Kwon J; Lee S; Kong H; Im SA; Lee YH; Lee YR; Oh ST; Jo TH; Park YI; Lee CK; Kim K
Phytomedicine; 2009 Sep; 16(9):856-63. PubMed ID: 19303272
[TBL] [Abstract][Full Text] [Related]
12. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice.
Jatwa R; Parmar HS; Panda S; Kar A
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):177-80. PubMed ID: 17697037
[TBL] [Abstract][Full Text] [Related]
14. Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats.
Chaturvedi P; George S; Milinganyo M; Tripathi YB
Phytother Res; 2004 Nov; 18(11):954-6. PubMed ID: 15597317
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus.
Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Liapis CD; Alevizos M
Diabet Med; 2008 Mar; 25(3):333-40. PubMed ID: 18307460
[TBL] [Abstract][Full Text] [Related]
16. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus.
Ashraf R; Aamir K; Shaikh AR; Ahmed T
J Ayub Med Coll Abbottabad; 2005; 17(3):60-4. PubMed ID: 16320801
[TBL] [Abstract][Full Text] [Related]
17. [Bitter melon to control high blood sugar].
Praxis (Bern 1994); 2004 Dec; 93(50):2118. PubMed ID: 15646680
[No Abstract] [Full Text] [Related]
18. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet.
Shih CC; Lin CH; Lin WL
Diabetes Res Clin Pract; 2008 Aug; 81(2):134-43. PubMed ID: 18550200
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
[TBL] [Abstract][Full Text] [Related]
20. Influence of therapy with metformin on the concentration of certain divalent cations in patients with non-insulin-dependent diabetes mellitus.
Doşa MD; Hangan LT; Crauciuc E; Galeş C; Nechifor M
Biol Trace Elem Res; 2011 Jul; 142(1):36-46. PubMed ID: 20567934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
